• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒表位表面的复杂性作为疫苗和治疗性抗体的逃避目标。

Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.

机构信息

Harvard Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, United States.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.

出版信息

Front Immunol. 2022 Jun 17;13:904609. doi: 10.3389/fimmu.2022.904609. eCollection 2022.

DOI:10.3389/fimmu.2022.904609
PMID:35784339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9247215/
Abstract

The dynamic interplay between virus and host plays out across many interacting surfaces as virus and host evolve continually in response to one another. In particular, epitope-paratope interactions (EPIs) between viral antigen and host antibodies drive much of this evolutionary race. In this review, we describe a series of recent studies examining aspects of epitope complexity that go beyond two interacting protein surfaces as EPIs are typically understood. To structure our discussion, we present a framework for understanding epitope complexity as a spectrum along a series of axes, focusing primarily on 1) epitope biochemical complexity (e.g., epitopes involving N-glycans) and 2) antigen conformational/dynamic complexity (e.g., epitopes with differential properties depending on antigen state or fold-axis). We highlight additional epitope complexity factors including epitope tertiary/quaternary structure, which contribute to epistatic relationships between epitope residues within- or adjacent-to a given epitope, as well as epitope overlap resulting from polyclonal antibody responses, which is relevant when assessing antigenic pressure against a given epitope. Finally, we discuss how these different forms of epitope complexity can limit EPI analyses and therapeutic antibody development, as well as recent efforts to overcome these limitations.

摘要

病毒和宿主之间的动态相互作用在许多相互作用的表面上展开,因为病毒和宿主不断相互进化以适应对方。特别是,病毒抗原和宿主抗体之间的表位-配体相互作用(EPIs)推动了这场进化竞赛。在这篇综述中,我们描述了一系列最近的研究,这些研究考察了表位复杂性的各个方面,超出了通常理解的 EPIs 仅限于两个相互作用的蛋白质表面。为了组织我们的讨论,我们提出了一个理解表位复杂性的框架,作为一系列轴上的一个谱,主要集中在 1)表位生化复杂性(例如,涉及 N-糖基化的表位)和 2)抗原构象/动态复杂性(例如,根据抗原状态或折叠轴具有不同特性的表位)。我们强调了其他表位复杂性因素,包括表位三级/四级结构,这有助于给定表位内或附近的表位残基之间的上位关系,以及多克隆抗体反应导致的表位重叠,这在评估针对给定表位的抗原压力时很重要。最后,我们讨论了这些不同形式的表位复杂性如何限制 EPI 分析和治疗性抗体的开发,以及最近克服这些限制的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c6d/9247215/d9b52c79d0ae/fimmu-13-904609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c6d/9247215/69262680c6f2/fimmu-13-904609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c6d/9247215/d9b52c79d0ae/fimmu-13-904609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c6d/9247215/69262680c6f2/fimmu-13-904609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c6d/9247215/d9b52c79d0ae/fimmu-13-904609-g002.jpg

相似文献

1
Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.病毒表位表面的复杂性作为疫苗和治疗性抗体的逃避目标。
Front Immunol. 2022 Jun 17;13:904609. doi: 10.3389/fimmu.2022.904609. eCollection 2022.
2
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
3
Beyond B-Cell Epitopes: Curating Positive Data on Antipeptide Paratope Binding to Support Peptide-Based Vaccine Design.超越 B 细胞表位:整理抗肽变构结合的阳性数据以支持基于肽的疫苗设计。
Protein Pept Lett. 2021;28(8):953-962. doi: 10.2174/0929866528666210218215624.
4
Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.灭活 H5 疫苗种株对不同鸭/广东谱系 H5N1 高致病性禽流感病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00720-20.
5
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.通过糖基工程改造冠状病毒聚糖护盾以呈现 α-半乳糖表位,增强潜在的 Covid-19 疫苗的免疫原性。
Vaccine. 2020 Sep 29;38(42):6487-6499. doi: 10.1016/j.vaccine.2020.08.032. Epub 2020 Aug 19.
6
Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition.变构表位的构象灵活性有限可能是 HIV 表位识别特异性退化的原因。
Int Immunol. 2013 Feb;25(2):77-90. doi: 10.1093/intimm/dxs093. Epub 2012 Sep 11.
7
SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture.严重急性呼吸综合征冠状病毒2型抗体有效性受非表位突变/表位三维结构结合诱导的变性影响。
Pathogens. 2022 Nov 29;11(12):1437. doi: 10.3390/pathogens11121437.
8
Mining for the antibody-antigen interacting associations that predict the B cell epitopes.挖掘预测B细胞表位的抗体-抗原相互作用关联。
BMC Struct Biol. 2010 May 17;10 Suppl 1(Suppl 1):S6. doi: 10.1186/1472-6807-10-S1-S6.
9
An integrative structure-based framework for predicting biological effects mediated by antipeptide antibodies.一种基于结构的综合框架,用于预测抗肽抗体介导的生物学效应。
J Immunol Methods. 2015 Dec;427:19-29. doi: 10.1016/j.jim.2015.09.002. Epub 2015 Sep 26.
10
Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations .具有 narrowly focused 流感病毒抗体的个体血清可快速选择病毒逃逸突变。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00859-18. Print 2018 Oct 1.

引用本文的文献

1
Structures and functions of the limited natural polyclonal antibody response to parvovirus infection.细小病毒感染有限的天然多克隆抗体反应的结构与功能。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2423460122. doi: 10.1073/pnas.2423460122. Epub 2025 Feb 14.
2
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.纳米抗体Nanosota-9作为抗奥密克戎治疗候选药物的发现。
PLoS Pathog. 2024 Nov 26;20(11):e1012726. doi: 10.1371/journal.ppat.1012726. eCollection 2024 Nov.
3
Quantification of full and empty particles of adeno-associated virus vectors via a novel dual fluorescence-linked immunosorbent assay.

本文引用的文献

1
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.通过定向进化拓宽 SARS-CoV-1 中和抗体以增强对 SARS-CoV-2 的中和作用。
Sci Signal. 2023 Aug 15;16(798):eabk3516. doi: 10.1126/scisignal.abk3516.
2
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail.SARS-CoV-2 刺突 E406W 突变体逃避临床单克隆抗体鸡尾酒的结构变化。
Cell Rep. 2023 Jun 27;42(6):112621. doi: 10.1016/j.celrep.2023.112621. Epub 2023 May 26.
3
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution.
通过一种新型双荧光酶联免疫吸附测定法对腺相关病毒载体的完整和空颗粒进行定量分析。
Mol Ther Methods Clin Dev. 2024 Jun 24;32(3):101291. doi: 10.1016/j.omtm.2024.101291. eCollection 2024 Sep 12.
4
A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies.一种编码天然严重急性呼吸综合征冠状病毒2刺突蛋白的候选DNA疫苗可诱导抗亚结构域1抗体。
Vaccines (Basel). 2023 Sep 3;11(9):1451. doi: 10.3390/vaccines11091451.
5
Viral Capsid, Antibody, and Receptor Interactions: Experimental Analysis of the Antibody Escape Evolution of Canine Parvovirus.病毒衣壳、抗体和受体相互作用:犬细小病毒抗体逃逸进化的实验分析。
J Virol. 2023 Jun 29;97(6):e0009023. doi: 10.1128/jvi.00090-23. Epub 2023 May 18.
6
Learned features of antibody-antigen binding affinity.抗体-抗原结合亲和力的习得特征。
Front Mol Biosci. 2023 Feb 21;10:1112738. doi: 10.3389/fmolb.2023.1112738. eCollection 2023.
病毒进化过程中 SARS-CoV-2 受体结合域突变约束的转变。
Science. 2022 Jul 22;377(6604):420-424. doi: 10.1126/science.abo7896. Epub 2022 Jun 28.
4
Drivers of adaptive evolution during chronic SARS-CoV-2 infections.慢性 SARS-CoV-2 感染期间适应性进化的驱动因素。
Nat Med. 2022 Jul;28(7):1501-1508. doi: 10.1038/s41591-022-01882-4. Epub 2022 Jun 20.
5
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.BA.2.12.1、BA.4 和 BA.5 逃避奥密克戎感染诱导的抗体。
Nature. 2022 Aug;608(7923):593-602. doi: 10.1038/s41586-022-04980-y. Epub 2022 Jun 17.
6
An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain.一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域突变的抗体逃逸估计器。
Virus Evol. 2022 May 11;8(1):veac021. doi: 10.1093/ve/veac021. eCollection 2022.
7
SARS-CoV-2 vaccination washes away original antigenic sin.新型冠状病毒2型疫苗接种消除了原始抗原罪。
Trends Immunol. 2022 Apr;43(4):271-273. doi: 10.1016/j.it.2022.02.009. Epub 2022 Feb 28.
8
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.SARS-CoV-2 奥密克戎亚谱系的抗体逃逸特性。
Nature. 2022 Apr;604(7906):553-556. doi: 10.1038/s41586-022-04594-4. Epub 2022 Mar 3.
9
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain.关于 SARS-CoV-2 奥密克戎变异株受体结合域突变特征的研究进展。
Cell Rep Med. 2022 Jan 24;3(2):100527. doi: 10.1016/j.xcrm.2022.100527. eCollection 2022 Feb 15.
10
Structure Based Affinity Maturation and Characterizing of SARS-CoV Antibody CR3022 against SARS-CoV-2 by Computational and Experimental Approaches.基于结构的亲和力成熟和计算与实验方法研究 SARS-CoV 抗体 CR3022 对 SARS-CoV-2 的作用。
Viruses. 2022 Jan 19;14(2):186. doi: 10.3390/v14020186.